Press Releases
Press Releases
-
July 17, 2019
Gilead Sciences Announces Changes to Senior Leadership Team -
July 17, 2019
Gilead Sciences’ Chief Scientific Officer John McHutchison to Leave the Company -
July 16, 2019
Gilead Sciences to Release Second Quarter 2019 Financial Results on Tuesday, July 30, 2019 -
July 16, 2019
Kite Announces Plans to Bolster Industry-Leading Cell Therapy Manufacturing Capabilities With New Viral Vector Facility -
July 14, 2019
Gilead and Galapagos Enter Into Transformative Research and Development Collaboration -
July 11, 2019
Gilead Appoints Christi L. Shaw as Chief Executive Officer of Kite -
July 11, 2019
Gilead Sciences and Renown Institute for Health Innovation Announce Strategic Collaboration to Advance Understanding of Nonalcoholic Steatohepatitis (NASH) -
July 1, 2019
Gilead Announces Intent to Submit New Drug Application for Filgotinib to U.S. Food and Drug Administration This Year -
June 26, 2019
Louisiana Launches Hepatitis C Innovative Payment Model With Asegua Therapeutics, Aiming to Eliminate the Disease -
June 24, 2019
Gilead and Carna Biosciences Announce Research and Development Collaboration to Develop Novel Immuno-Oncology Therapies